NICHOLAS KOLINSKY: Open Payments
NPI 1033569439 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261,497 in 448 payments from 28 companies in 2025. Trend: 2023 $9,519 · 2024 $190,024 · 2025 $261,497
Speaker / faculty: $223,360Travel & lodging: $16,323Food & beverage: $11,607Consulting: $6,482Honoraria: $3,658Education: $67
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 184 | $159,696 |
| Regeneron Healthcare Solutions, Inc. | 40 | $33,142 |
| Ionis Pharmaceuticals, Inc. | 25 | $18,541 |
| CSL Behring | 38 | $15,175 |
| GlaxoSmithKline, LLC. | 29 | $14,642 |
| Grifols USA, LLC | 18 | $4,677 |
| GENZYME CORPORATION | 15 | $4,649 |
| Blueprint Medicines Corporation | 7 | $4,109 |
| Incyte Corporation | 3 | $2,257 |
| Grifols Shared Services North America, Inc. | 1 | $1,328 |
Products named: AIRSUPRA, TEZSPIRE, DUPIXENT, FASENRA, DAWNZERA, Andembry, NUCALA, Xembify.
Industry payments across TN — which companies pay providers there.
